Abstract:An increasing portion of patients with HIV infection and/or AIDS cannot use currently FDA-approved anti-HIV drugs, including the reverse transcriptase and protease inhibitors, due to the adverse effects and the emergence of drug resistance. Thus, it is essential to develop new anti-HIV agents with a target different from the HIV reverse transcriptase and protease. Using a conformation-specific monoclonal antibody NC-1, we previously established a high throughput screening assay for identification of small molecular organic compounds that disrupt the HIV-1 gp41 six-helix bundle formation, a critical step of membrane fusion between the HIV and the target cell. In the present study, we used this assay to screen for inhibitors of the gp41 six-helix bundle formation from aqueous extracts of nine Chinese medicinal herbs with antiviral activity. We found that the extracts of two herbs, Prunella vulgaris and Rhizoma cibotte, showed potent inhibitory activity. The inhibitory activity of these two herb extracts significantly decreased after they were passed through polyamide resin mini-columns, which are able to bind polyphenols including tannin, an HIV-1 inhibitor with multiple mechanisms of action. The bound polyphenols were eluted from the polyamide columns and also showed potent inhibitory activity on the gp41 six-helix bundle formation. Tannin purchased from different commercial sources inhibited the gp41 six-helix bundle formation in a manner similar to the polyphenols isolated from the herb extracts. These results suggest that tannin may be one of major inhibitors of the HIV-1 gp41 six-helix bundle formation in the herb extracts and that tannin may inhibit HIV-1 entry by disrupting the gp41 six-helix bundle formation.

Anti-HIV Tigliane Diterpenoids from Reutealis Trisperma.

Terpenoids from Tripterygium Wilfordii

LC-MS Identification, Isolation, and Structural Elucidation of Anti-HIV Tigliane Diterpenoids from Wikstroemia lamatsoensis

Three new nortriterpenoids from Schisandra wilsoniana and their anti-HIV-1 activities

Discovery and Synthesis of Novel Beesioside I Derivatives with Potent Anti-Hiv Activity.

Anti-HIV Tigliane Diterpenoids from Wikstroemia scytophylla

Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.

Rapid Recognition And Targeted Isolation Of Anti-Hiv Daphnane Diterpenes From Daphne Genkwa Guided By Uplc-Msn

Stelleralides D–J and Anti-HIV Daphnane Diterpenes from Stellera Chamaejasme

Structure and bioactivity of triterpenoids from the stems of Schisandra sphenanthera

Total Syntheses of Phorbol and 11 Tigliane Diterpenoids and Their Evaluation as HIV Latency-Reversing Agents

Isolation, Structure Determination, and Anti-Hiv Evaluation of Tigliane-Type Diterpenes and Biflavonoid from Stellera Chamaejasme.

Cytotoxic tigliane-type diterpenoids from Croton tiglium

Diterpenoids from Euphorbia lactea and their anti-HIV-1 activity

New phorbol ester derivatives as potent anti-HIV agents

New Lignans from the Leaves and Stems of Schisandra chinensis and Their Anti‐HIV‐1 Activities

Schilancitrilactones A–C: Three Unique Nortriterpenoids from Schisandra Lancifolia

Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora.

Undescribed abietane-type diterpenoids and oleanane-type triterpenoids from the stem and branch of Tripterygium wilfordii

Terpenoids from Tripterygium hypoglaucum and Their Anti-Inflammatory Activity

Potent Anti-HIV Ingenane Diterpenoids from Euphorbia Ebracteolata